We are live on ! Find out more
Skandinaviska Enskilda Banken (SEB)

Skandinaviska Enskilda Banken (SEB) Portfolio holdings

AUM $2.66B
1-Year Est. Return 26.2%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+26.2%
3 Year Est. Return
+111.17%
5 Year Est. Return
+154.66%
10 Year Est. Return
+614.64%
AUM
$22.1B
AUM Growth
+$448M
Cap. Flow
-$220M
Cap. Flow %
-1%
Top 10 Hldgs %
37.73%
Holding
895
New
69
Increased
353
Reduced
280
Closed
55

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$239M
2
GILD icon
Gilead Sciences
GILD
+$97.8M
3
CRM icon
Salesforce
CRM
+$97.5M
4
TXN icon
Texas Instruments
TXN
+$62.9M
5
MA icon
Mastercard
MA
+$49.5M

Sector Composition

Rank Sector Weight
1 Technology 38.33%
2 Healthcare 14.43%
3 Financials 12.54%
4 Consumer Discretionary 12.12%
5 Communication Services 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCRN
651
DELISTED
Cross Country Healthcare
CCRN
$1.08M ﹤0.01%
+60,000
New +$808K
AGIO icon
652
Agios Pharmaceuticals
AGIO
$2.01B
$1.08M ﹤0.01%
32,790
+3,430
+12% +$161K
OTEX icon
653
Open Text
OTEX
$5.83B
$1.05M ﹤0.01%
36,850
PAAS icon
654
Pan American Silver
PAAS
$20.1B
$1.04M ﹤0.01%
52,257
-1,300
-2% -$29.1K
WLK icon
655
Westlake Corp
WLK
$10.2B
$1.03M ﹤0.01%
9,101
HAS icon
656
Hasbro
HAS
$13.5B
$1.01M ﹤0.01%
+18,067
New +$1.18M
BEN icon
657
Franklin Resources
BEN
$17.1B
$996K ﹤0.01%
49,545
EVRI
658
DELISTED
Everi Holdings
EVRI
$981K ﹤0.01%
72,798
+16,501
+29% +$221K
PATH icon
659
UiPath
PATH
$7.78B
$975K ﹤0.01%
76,514
ABCL icon
660
AbCellera Biologics
ABCL
$3.27B
$960K ﹤0.01%
340,267
VERA icon
661
Vera Therapeutics
VERA
$2.13B
$938K ﹤0.01%
22,290
+5,189
+30% +$230K
VIPS icon
662
Vipshop
VIPS
$6.77B
$931K ﹤0.01%
70,114
+7,606
+12% +$109K
BLD
663
DELISTED
TopBuild
BLD
$920K ﹤0.01%
2,958
-1,517
-34% -$556K
CRNX icon
664
Crinetics Pharmaceuticals
CRNX
$8.96B
$918K ﹤0.01%
+18,117
New +$1.01M
HASI icon
665
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.41B
$913K ﹤0.01%
+34,200
New +$1.07M
TBNK
666
DELISTED
Territorial Bancorp Inc.
TBNK
$905K ﹤0.01%
92,971
-18,835
-17% -$199K
GERN icon
667
Geron
GERN
$1B
$893K ﹤0.01%
+262,649
New +$1.05M
DNLI icon
668
Denali Therapeutics
DNLI
$4.02B
$875K ﹤0.01%
43,245
YETI icon
669
Yeti Holdings
YETI
$3.37B
$873K ﹤0.01%
22,600
BCRX icon
670
BioCryst Pharmaceuticals
BCRX
$2.52B
$859K ﹤0.01%
114,063
LNTH icon
671
Lantheus
LNTH
$6.59B
$847K ﹤0.01%
9,500
-32,500
-77% -$3.17M
IMVT icon
672
Immunovant
IMVT
$8.73B
$843K ﹤0.01%
35,316
-53,152
-60% -$1.51M
ML
673
DELISTED
MoneyLion Inc.
ML
$842K ﹤0.01%
+9,752
New +$658K
WFG icon
674
West Fraser Timber
WFG
$5.53B
$839K ﹤0.01%
9,744
+580
+6% +$54.4K
PLRX icon
675
Pliant Therapeutics
PLRX
$67.5M
$839K ﹤0.01%
65,582

Similar funds

Skandinaviska Enskilda Banken (SEB)'s Q4 2024 Portfolio in Review

As of Q4 2024, Skandinaviska Enskilda Banken (SEB) held 895 positions worth $22.1B, up 2.1% from $21.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Skandinaviska Enskilda Banken (SEB)'s Q4 2024 filing shows 69 new, 353 increased, 280 reduced and 55 closed positions. Its largest new stake was ExxonMobil: 81,206 shares worth $8.59M. The largest sale was Microsoft, an estimated $160M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Financials.

  • Skandinaviska Enskilda Banken (SEB)'s largest Q4 2024 buy was ExxonMobil: 81,206 shares worth $8.59M.
  • Skandinaviska Enskilda Banken (SEB) added most to Apple in Q4 2024, an estimated $239M increase.
  • Skandinaviska Enskilda Banken (SEB)'s biggest Q4 2024 reduction was Microsoft, cutting an estimated $160M.
  • Skandinaviska Enskilda Banken (SEB) fully exited L3Harris in Q4 2024, selling an estimated $19.2M.
  • Skandinaviska Enskilda Banken (SEB)'s ten largest holdings make up 38% of its $22.1B portfolio in Q4 2024.
  • Skandinaviska Enskilda Banken (SEB) opened 69 new positions and closed 55 in Q4 2024.
  • Skandinaviska Enskilda Banken (SEB)'s portfolio value rose 2.1% quarter-over-quarter to $22.1B.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2024, filed 10 Feb 2025.